NCT03894852View on ClinicalTrials.gov

SRSF2 Gene Mutation in Patients With t-MDS/AML

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

June 2, 2019

Primary Completion Date

December 29, 2019

Study Completion Date

April 29, 2020

Conditions
Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
Interventions
DIAGNOSTIC_TEST

PCR and cytogenetics

detection of SRSF2 gene mutation and cytogenetic studies

Trial Locations (2)

71515

Assiut, Asyut

Zeinab Albadry Mohammed Zahran, Asyut

All Listed Sponsors
lead

Zeinab Albadry Mohammed Zahran

OTHER

NCT03894852 - SRSF2 Gene Mutation in Patients With t-MDS/AML | Biotech Hunter | Biotech Hunter